News | April 16, 2026
Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
The new outpatient-focused clinic is designed to address voice, airway and swallowing disorders through advanced diagnostics
Subscribe To Our Newsletter & Stay Updated
